VRCA EPS Estimates
Verrica Pharmaceuticals Inc.
$4.14
-$0.07(-1.66%)
30
Overall
40
Value
10
Tech
42
Quality
Market Cap
$72.32M
Volume
47.55K
52W Range
$3.28 - $9.82
Target Price
$13.83
VRCA EPS estimates: the consensus estimate for Verrica Pharmaceuticals Inc.'s current fiscal year is -$2.25 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VRCA EPS Estimates
- EPS estimate, current quarter
- $-0.63
- EPS estimate, next quarter
- $-0.63
- EPS estimate, current year
- $-2.25
- EPS estimate, next year
- $-2.00
- EPS growth, 3-year
- +38.44%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.68 |
| 2024 | $-14.80 |
| 2023 | $-14.80 |
| 2022 | $-7.20 |
| 2021 | $-13.00 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRCA | $4.14 | -1.7% | 47.55K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Verrica Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW